Pfizer Long-Term Investments 2010-2024 | PFE

Pfizer long-term investments for the quarter ending September 30, 2024 were $10.762B, a 24.42% decline year-over-year.

  • Pfizer long-term investments for 2023 were $15.368B, a 1.98% increase from 2022.
  • Pfizer long-term investments for 2022 were $15.069B, a 30% decline from 2021.
  • Pfizer long-term investments for 2021 were $21.526B, a 6.24% increase from 2020.

Pfizer Long-Term Investments 2010-2024 | PFE

  • Pfizer long-term investments for 2023 were $15.368B, a 1.98% increase from 2022.
  • Pfizer long-term investments for 2022 were $15.069B, a 30% decline from 2021.
  • Pfizer long-term investments for 2021 were $21.526B, a 6.24% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B